Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways.
Marwa Monier Mahmoud RefaieRehab Ahmed RifaaiAsmaa M A BayoumiSayed ShehataPublished in: The Journal of pharmacy and pharmacology (2023)
Sac/Val has an important cardioprotective effect against CIS cardiotoxicity with the involvement of eNOS.